Literature DB >> 17418389

Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia.

Amy Fleischman1, Harriet Paltiel, Jeanne Chow, Julie Ringelheim, Catherine M Gordon.   

Abstract

UNLABELLED: Hyperandrogenism and hyperinsulinism have both been suggested as etiologic factors behind functional ovarian hyperandrogenism or polycystic ovary syndrome. Females with congenital adrenal hyperplasia provide a clinical model to evaluate the contribution of pre- and post-natal hyperandrogenism on ovarian structure and function. STUDY
OBJECTIVE: To evaluate glucose tolerance, and structure and androgen production of the ovaries in young females with classic congenital adrenal hyperplasia. DESIGN, SETTING, PARTICIPANTS: Cross-sectional study, including the enrollment of participants, ages 8 to 20 years, recruited from the pediatric endocrinology clinical program of a tertiary pediatric referral center.
INTERVENTIONS: Ten participants had oral glucose tolerance testing, adrenal and ovarian androgen measurements, and pelvic ultrasound studies performed. MAIN OUTCOME MEASURES: Presence of altered response to glucose challenge, ovarian hyperandrogenism, or presence of polycystic ovaries by ultrasound.
RESULTS: Measurements of fasting blood glucose, post-challenge glucose, and insulin resistance were normal in this sample. There was no evidence of ovarian hyperandrogenism after adrenal suppression with dexamethasone. All participants had normal ovarian structure without evidence of polycystic ovaries.
CONCLUSIONS: Females with classic congenital adrenal hyperplasia (21-hydroxylase deficiency) and normal glucose tolerance appear to have normal ovarian structure and function during the peripubertal period.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418389      PMCID: PMC3206607          DOI: 10.1016/j.jpag.2006.08.001

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  19 in total

Review 1.  Congenital adrenal hyperplasia.

Authors:  Phyllis W Speiser; Perrin C White
Journal:  N Engl J Med       Date:  2003-08-21       Impact factor: 91.245

2.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

3.  Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children.

Authors:  Gabriel I Uwaifo; Erica M Fallon; Jeff Chin; Jane Elberg; Shamik J Parikh; Jack A Yanovski
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

4.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

Authors:  Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

Authors:  E Bonora; G Targher; M Alberiche; R C Bonadonna; F Saggiani; M B Zenere; T Monauni; M Muggeo
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

6.  Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.

Authors:  Evangelia Charmandari; Martina Weise; Stefan R Bornstein; Graeme Eisenhofer; Margaret F Keil; George P Chrousos; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

Review 7.  Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Growth, development, and therapeutic considerations.

Authors:  C J Migeon; A B Wisniewski
Journal:  Endocrinol Metab Clin North Am       Date:  2001-03       Impact factor: 4.741

8.  Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia.

Authors:  F J Paula; L M Gouveia; G M Paccola; C E Piccinato; A C Moreira; M C Foss
Journal:  Horm Metab Res       Date:  1994-11       Impact factor: 2.936

9.  Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.

Authors:  R B Barnes; R L Rosenfield; D A Ehrmann; J F Cara; L Cuttler; L L Levitsky; I M Rosenthal
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958

10.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

View more
  1 in total

1.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.